Legal 500
  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Contact Us
  • Article

    EDPB Reports On EU Data Protection Authorities' Resources And Enforcement Actions

    Earlier this month, the European Data Protection Board (EDPB) published a report on the resources that the EU Member States make available to their Data Protection Authorities (DPA)...
    European UnionPrivacy
    Alston & Bird
    Alston & Bird
  • Article

    Look Ahead To The Week Of February 28: State Of The Union, Ukraine, And USPS Changes

    The Senate will take up legislation that would implement changes at the U.S. Postal Service, as well as consideration of H.R. 3755, the Women's Health Protection Act of 2021, and the Affordable Insulin Now Act...
    GlobalFood, Drugs, Healthcare, Life Sciences
    Alston & Bird
    Alston & Bird
  • Article

    New CFPB Chief Rohit Chopra Confirmed By Senate And Takes Immediate Action Against Big Tech Firms

    On September 30, 2021, the Senate confirmed Rohit Chopra to serve as director of the Consumer Financial Protection Bureau (CFPB)
    United StatesConsumer Protection
    Alston & Bird
    Alston & Bird
  • Article

    New Proposed Registration Requirements For Covered Financial Products And Services Under The California Consumer Financial Protection Law

    Last year, California passed the California Consumer Financial Protection Law ("CCFPL"), which renamed the Department of Business Oversight as the Department of Financial Protection...
    United StatesConsumer Protection
    Alston & Bird
    Alston & Bird
  • Article

    COVID-19 Medical Products Supply Chain Week In Review – July 6, 2021

    Last week, the White House released a framework for U.S. leadership in the global COVID-19 response. In addition, the FDA is revoking the emergency use authorizations (EUAs) ...
    United StatesCoronavirus (COVID-19)
    Alston & Bird
    Alston & Bird
  • Article

    SEC Approves Nasdaq Board Diversity Rule

    On August 6, 2021, the SEC approved Nasdaq's Board Diversity Rule, which is designed to provide stakeholders with insight into a company's current board composition and encourage board diversity for companies.
    United StatesCorporate/Commercial Law
    Alston & Bird
    Alston & Bird
  • Article

    COVID-19 Medical Products Supply Chain Week In Review – May 24, 2021

    In the past week, President Biden revealed a new plan to share COVID-19 vaccines with other countries, and the CDC allowed vaccination sites to prioritize vaccinations over minimizing waste...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Alston & Bird
    Alston & Bird
  • Article

    FDA To Develop National Standards For Drug Distributors – Medical Products Supply Chain Week In Review

    Since our last update, the Senate confirmed Dr. Robert Califf as commissioner of the U.S. Food and Drug Administration. The FDA resumed domestic and foreign inspections.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Alston & Bird
    Alston & Bird
  • Article

    Medical Products Supply Chain Week In Review – August 18, 2021

    Last week, the FDA amended the Moderna and Pfizer-BioNTech emergency use authorizations (EUAs) to allow an additional dose of the mRNA COVID-19 vaccine for immunocompromised individuals.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Alston & Bird
    Alston & Bird
  • Article

    Medical Products Supply Chain Week In Review – August 31, 2021

    Last week, the White House COVID-19 Response Team encouraged school systems to implement a layered approach to prevention as schools return to in-person learning.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Alston & Bird
    Alston & Bird
  • Article

    Medical Products Supply Chain Week In Review – FDA Authorizes Pfizer And Moderna Booster For All Adults

    In the past week, the FDA authorized the Pfizer and Moderna booster shots for all adult age groups, while the CDC Advisory Committee on Immunization Practices (ACIP) also recommended the Moderna vaccine booster for all adults.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Alston & Bird
    Alston & Bird
  • Article

    Medical Products Supply Chain Week In Review – July 12, 2021

    Last week, President Biden signed a comprehensive pro-competition Executive Order with various requirements affecting medical product supply chains, such as the ability to import prescription...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Alston & Bird
    Alston & Bird
  • Article

    Medical Products Supply Chain Week In Review – October 14, 2021

    Last week, AstraZeneca and Merck filed emergency use authorization (EUA) requests for their COVID-19 drugs.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Alston & Bird
    Alston & Bird
  • Article

    Medical Products Supply Chain Week In Review – October 7, 2021

    Last week, the U.S.-EU Trade and Technology Council (TTC) held an inaugural meeting and discussed supply chain issues. The White House COVID-19 Response Team reported a decrease in case rates and hospitalizations.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Alston & Bird
    Alston & Bird
  • Article

    Look Ahead To The Week Of December 13: Waiting On The Senate

    Last week, the House and Senate passed legislation to facilitate an increase in the debt ceiling, which has teed up a vote for final passage this week.
    United StatesGovernment, Public Sector
    Alston & Bird
    Alston & Bird
  • Article

    Look Ahead To The Week Of January 10: The Fight For Voting Rights

    Both the House and Senate will be in session this week.
    United StatesGovernment, Public Sector
    Alston & Bird
    Alston & Bird
  • Article

    Patent Case Summaries For The Week Ending November 12, 2021

    A weekly summary of the precedential patent-related opinions issued by the Court of Appeals for the Federal Circuit and the opinions designated precedential or informative by the Patent Trial and Appeal Board.
    United StatesIntellectual Property
    Alston & Bird
    Alston & Bird
  • Article

    2021 Developments In State Cybersecurity Safe Harbor Laws

    Only four months in and 2021 has already been a big year for state cybersecurity safe harbor legislation. Two states, Utah and Connecticut, have recently enacted or introduced a breach litigation...
    United StatesTechnology
    Alston & Bird
    Alston & Bird
  • Article

    CISA Releases Advisory Concerning Chinese-Backed Threat Actor

    On September 27, 2023, The U.S. National Security Agency (NSA), the U.S. Federal Bureau of Investigation (FBI), the U.S. Cybersecurity and Infrastructure Security Agency (CISA)...
    United StatesTechnology
    Alston & Bird LLP
    Alston & Bird LLP
  • Article

    FDA Extends Pause On Non-mission-critical Domestic Surveillance Inspections To February 4 – Medical Products Supply Chain Week In Review

    Previously, Robert Califf previewed his priorities, if confirmed, to the Senate HELP Committee.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Alston & Bird
    Alston & Bird

Showing 121–140 of 482 results

PreviousNext
Legal Intelligence Newsletters